Final Glance: Biotechnology companies
AP - Wed Jun 25, 5:09PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Midday Glance: Biotechnology companies
AP - Wed Jun 25, 12:36PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
'Fast Money' Recap: A Mixed Bag for Housing
at The Street - Wed Jun 25, 4:00AM CDT
The trading panel discussed the stock market's big drop, how low the S&P can go and why bonds aren't selling off.
Early Glance: Biotechnology companies
AP - Tue Jun 24, 9:52AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Celgene, Chipotle, Keurig Remain In Buying Range
at Investor's Business Daily - Mon Jun 23, 6:52PM CDT
This week's Big Cap 20 list showed a few changes from last week, as Apple (AAPL), Encana (ECA) and Magna International (MGA) fell out and were replaced by Celgene (CELG), Spectra Energy (SE) and Southwest Airlines (LUV) . Energy plays still dominate...
Stocks Poised For Soft Start; Micros Systems Surges Premarket
at Investor's Business Daily - Mon Jun 23, 7:56AM CDT
The stock market today appeared poised for a mildly lower start despite upbeat Chinese factory data and a round of deal news. Nasdaq 100 futures fell 2 points vs. fair value, while S&P 500 futures edged down less than 1 point. Dow futures lost 12...
Celgene Sees Better Results For Psoriatic Arthritis
at Investor's Business Daily - Fri Jun 20, 5:12PM CDT
When a large biotechnology company has a wonder drug, it makes sense to see if the product can treat multiple diseases. Celgene (CELG) has done well in this regard. In January, Celgene's key drug Abraxane won approval in Europe for use in combination...
Stocks Hold Slim Gains; Celgene, Salix Rally
at Investor's Business Daily - Fri Jun 20, 2:02PM CDT
The major stock indexes continued to trade modestly higher late Friday and were on pace to end the week with gains of more than 1%. The Dow Jones industrial average rose 0.2%. The broader Nasdaq and the S&P 500 edged up 0.1% each. Amid quadruple...
Celgene (CELG) Approaches New Upside Target of $171.95
Comtex SmarTrend(R) - Fri Jun 20, 12:28PM CDT
Celgene (NASDAQ:CELG) has opened bullishly above the pivot of $166.67 today and has reached the first level of resistance at $170.13. Investors may be interested in a cross of the next upside pivot targets of $171.95 and $177.23.
Celgene Rises on Yet Another Stock Split - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 10:30AM CDT
Shares of Gelgene (CELG) gained following the approval of a stock split.
Shares of CELG Up 12.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jun 20, 9:33AM CDT
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on May 1st, 2014 at $147.87. In approximately 2 months, Celgene has returned 12.94% as of today's recent price of $167.00.
Company News for June 20, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 9:06AM CDT
Companies in the News are: BBRY,RAD,CELG,KR
Celgene's stockholders authorises two-for-one common stock split
M2 - Fri Jun 20, 5:39AM CDT
Biopharmaceutical company Celgene (NasdaqGS:CELG) said on Thursday that its stockholders have approved a two-for-one stock split of its common stock at its Annual Meeting of Stockholders held on 18 June 2014.
'Mad Money' Lightning Round: Buy, Buy, Buy Stryker
at The Street - Fri Jun 20, 5:00AM CDT
Cramer prefers Celgene over Gilead Sciences, Palo Alto Networks over OSI Systems and is discouraged by IBM.
'Fast Money' Recap: Late-Day Rally, Another Record High
at The Street - Fri Jun 20, 4:00AM CDT
The trading panel looked at gold and oil as the S&P hit another record high.